• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL EPIC¿ SUPRA VALVE (AORTIC); HEART-VALVE, NON-ALLOGRAFT TISSUE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL EPIC¿ SUPRA VALVE (AORTIC); HEART-VALVE, NON-ALLOGRAFT TISSUE Back to Search Results
Catalog Number ESP200-23
Medical Device Problem Codes Nonstandard Device (1420); Incomplete Coaptation (2507)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 08/01/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that on (b)(6) 2024, a 23mm epic valve was selected for implant.During the procedure, it was noted that when the valve was implanted that the leaflets didn't coapt properly.The device was removed and replaced with a non-abbott valve, while still on bypass, to resolve the event.The physician said that the profile of the valve does not match the sizer.There was no clinically significant delay and the patient remained hemodynamically stable throughout the procedure.There were no adverse consequences due to the performance of the device.The patient is stable.
 
Additional Manufacturer Narrative
The device is expected to be returned for evaluation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.
 
Additional Manufacturer Narrative
An event of incomplete coaptation and nonstandard device was reported.The valve was returned to abbott for analysis.All three cusps were flexible and contained no tears, perforations or anomalies.All cusps were mobile when manually manipulated.Functional testing at the time of manufacturing and upon return to abbott indicated that the valve functioned normally.During this test, which ensures proper cuspal coaptation and hemodynamic performance, the valve was placed in a pulse duplicator filled with saline.The conditions included a beat rate of 70 ± 1 bpm, a flow rate of 5.0 ± 0.2 lpm, and a mean aortic pressure of 100 +10/-0 mmhg.Under these conditions, the leaflets appeared to coapt such that the regurgitant fraction value was 1.9%.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed, and the product met all specifications.The cause of the reported event could not be conclusively determined.There is no indication of a product quality issue with respect to labeling design or manufacturing of the device.
 
Event or Problem Description
It was reported that on (b)(6) 2024, a 23mm epic valve was selected for implant.During the procedure, it was noted that when the valve was implanted that the leaflets didn't coapt properly.The device was removed and replaced with a non-abbott valve, while still on bypass, to resolve the event.The physician said that the profile of the valve does not match the sizer.There was no clinically significant delay and the patient remained hemodynamically stable throughout the procedure.There were no adverse consequences due to the performance of the device.The patient is stable.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EPIC¿ SUPRA VALVE (AORTIC)
Common Device Name
HEART-VALVE, NON-ALLOGRAFT TISSUE
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
ST. JUDE MEDICAL LTDA. REG#3001883144
1301rua profvieira demendonça
bairro engenho nogueira 31.31 0-26
BR   31.310-260
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
6517565400
MDR Report Key20096580
Report Number2135147-2024-04218
Device Sequence Number7748184
Product Code LWR
UDI-Device Identifier05415067033130
UDI-Public(01)05415067033130(17)271108(10)BR00041591
Combination Product (Y/N)N
Initial Reporter CountryCO
PMA/510(K) Number
P040021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Device Explanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other
Type of Report Initial,Followup
Report Date (Section B) 11/14/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Catalogue NumberESP200-23
Device Lot NumberBR00041591
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? No
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 08/06/2024
Supplement Date Received by Manufacturer11/11/2024
Initial Report FDA Received Date08/29/2024
Supplement Report FDA Received Date11/14/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured11/09/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient Age59 YR
Patient SexUnknown
Patient Weight73 KG
-
-